Beyond Air

Beyond Air is in the process of developing a generator and delivery system for nitric oxide to cater to the significant unmet requirements of patients with specific severe lung infections and respiratory ailments. We are keen to receive your input. Beyond Air Ltd. has been our wholly-owned subsidiary since June 2016. Mr. Lisi previously held the position of Senior Vice President of Business and Corporate Development at Avadel Pharmaceuticals (AVDL), where he played a crucial role in reorganizing the company, securing $121 million in funding, and steering its growth from a $100 million enterprise value to $1 billion within three years.